Sleep -Sleep isn’t a one-size-fits-all process. We all know it’s essential for good health, but what’s less discussed is how you sleep can be just as important as how much you sleep.
Cognitive Disability – Over the past decade, the prevalence of self-reported cognitive disability among U.S. adults has risen markedly, highlighting a potentially growing public health concern. A recent study published in Neurology examined data from the Centers for Disease Control and Prevention’s Behavioral Risk Factor Surveillance System (BRFSS) spanning 2013 to 2023 (excluding 2020) and found that cognitive disability
Epilepsy – Periodic Limb Movements during Sleep (PLMS) are repetitive, involuntary movements of the limbs (usually legs), typically occurring in sleep at regular intervals (every ~20-40 seconds), each lasting a few seconds. They may result in arousals or sleep fragmentation,
Introduction: Childhood Loneliness as a Public Health Concern
Childhood loneliness—defined as the subjective feeling of social isolation, disconnection, or lack of companionship during early development—has been increasingly recognized as a risk factor with long-term implications for mental and cognitive health. While loneliness is often seen as an emotional issue of childhood, research now indicates that its effects can extend well into adulthood, influencing brain function and increasing vulnerability to cognitive decline. Understanding this connection is critical for developing early interventions that safeguard cognitive aging and promote lifelong mental well-being.
Popular Chronic – Gabapentin is a commonly prescribed medication initially developed to treat seizures. Over the years, its use has expanded dramatically to include the treatment of chronic pain, especially nerve-related pain, as well as conditions like anxiety, sleep disorders, and restless leg syndrome. Due to its perceived low risk for abuse compared to opioids, gabapentin has become a popular alternative for long-term pain management.
Leqembi Found Safe for Use in Memory Clinics: A Step Forward in Alzheimer’s Treatment Accessibility. Leqembi (lecanemab), a monoclonal antibody developed by Eisai and Biogen, has recently been recognized as safe for use in memory clinics, marking a significant advancement in the treatment of early-stage Alzheimer’s disease
Alzheimer’s disease, a progressive neurodegenerative disorder, affects millions of people worldwide, leading to memory loss, cognitive…
Stroke is one of the leading causes of disability and death worldwide, with ischemic stroke accounting
Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system (CNS), leading to neurological disability..
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and spinal cord.
